We determined that these 44 chemical compounds are associated with the core targets caspase 3 (CASP3), TNF, and the kinase AKT1, which function primarily in the TNF and p53 signaling pathways in the treatment of GC. This evidence concerns the gene CASP3 and gastric cancer.